ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

A new blood test for colorectal cancer screening is being implemented in Alabama to improve early detection and reduce deaths from the disease.

Globally, colorectal cancer (CRC) is the second leading cause of cancer death and the third most common incident cancer. CRC begins as adenomatous or serrated polyps, and in particular as advanced ...

The American Cancer Society updated its colorectal cancer screening guidelines May 27 to include new blood- and stool-based screening options, while making clear that the blood-based test is a last ...

Nearly 18 million women in the U.S. aged 45 to 64 years are likely overdue for breast, cervical or colorectal cancer screenings, and more than 3 million are estimated to not be up to date on all three ...